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ABSTRACT
Few gene targets of Visual System Homeobox 2 (VSX2) have been identified despite its broad
and critical role in the maintenance of neural retina (NR) fate during early retinogenesis. We
performed VSX2 ChIP-seq and ChIP-PCR assays on early stage optic vesicle-like structures (OVs)
derived from human iPS cells (hiPSCs), which highlighted WNT pathway genes as direct regula-
tory targets of VSX2. Examination of early NR patterning in hiPSC-OVs from a patient with a
functional null mutation in VSX2 revealed mis-expression and upregulation of WNT pathway
components and retinal pigmented epithelium (RPE) markers in comparison to control hiPSC-
OVs. Furthermore, pharmacological inhibition of WNT signaling rescued the early mutant pheno-
type, whereas augmentation of WNT signaling in control hiPSC-OVs phenocopied the mutant.
These findings reveal an important role for VSX2 as a regulator of WNT signaling and suggest
that VSX2 may act to maintain NR identity at the expense of RPE in part by direct repression of
WNT pathway constituents. STEM CELLS 2016;34:2625–2634
SIGNIFICANCE STATEMENT
This study utilizes an hiPSC model of a retinal developmental disorder to gain insight into a
novel mechanism underlying neural retinal (NR) vs. RPE fate choice during human retinogene-
sis. Using pharmacological manipulation and chromatin immunoprecipitation followed by mas-
sively parallel DNA sequencing, we show that the NRPC transcription factor VSX2 is a direct
regulator of numerous WNT-related genes and that VSX2-mediated antagonism of WNT signal-
ing plays an important role in the maintenance of NR identity at the expense of RPE. Our find-
ings also underscore the utility of hiPSCs in investigating the earliest stages of human ocular
development, which are otherwise inaccessible to study.
INTRODUCTION
The vertebrate eye develops from the anterior
neural plate during late gastrulation as a result
of intrinsic programming and signals from sur-
rounding tissues, which in turn leads to the
expression of a group of transcription factors
that specify the eye field [1, 2]. Following eye
field specification, the bilateral optic pits evagi-
nate to form optic vesicles (OVs). OVs then
undergo invagination, resulting in the creation
of the bilayered optic cup, the inner and outer
aspects of which become the neural retina
(NR) and retinal pigmented epithelium (RPE),
respectively.
OV patterning, optic cup formation, and
subsequent retinal maturation are influenced
by inductive signaling molecules, which are
thought to include Fgfs [3–5], Tgfb superfamily
members, Hedgehog, [6, 7] and/or Wnts
[8–12]. In addition to extrinsic instructional
cues, there are multiple transcription factors
that play crucial roles in early RPE and NR
development. Two such factors are
Microphthalmia-associated transcription factor
(Mitf) and Visual system homeobox 2 (Vsx2).
Mitf is initially expressed uniformly throughout
the early mammalian OV, while at later stages
its expression is restricted to the RPE, where it
is involved in differentiation, proliferation, and
pigmentation [13, 14]. The initiation of this
restriction coincides with the onset of Vsx2
expression in the distal OV, which also serves
to demarcate the future NR. Vsx2 is involved
in maintenance and proliferation of the neural
retinal progenitor cell (NRPC) pool, timing of
photoreceptor production, and differentiation
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of one type of retinal interneuron, the bipolar cell [15–18]. In
addition, Vsx2 has been shown to inhibit Mitf expression
directly by binding and repressing Mitf promoter sites [19,
20], as well as through protein-protein interactions [21]. Dis-
ruption of Vsx2 in animal models causes retinal defects,
microphthalmia, and RPE layer duplication [15, 18, 21]; simi-
larly, in humans VSX2 mutations result in very small, nonfunc-
tional eyes with malformed retinas [22–24]. However, the
mechanism by which VSX2 influences these diverse processes
remains the subject of investigation.
VSX2 expression has also been used in vitro to identify
multipotent NRPCs derived from human pluripotent stem cells
(hPSCs) [25–29]. In order to study the role of VSX2 in human
retinogenesis and hPSC differentiation, we previously gener-
ated human induced PSCs (hiPSCs) from a microphthalmic
individual bearing a homozygous R200Q mutation in VSX2
(VSX2R200Q) and an unaffected sibling. The R200Q mutation
eliminates the ability of VSX2 to bind DNA [21, 24, 30], thus
rendering it unable to directly regulate gene expression. Pop-
ulations of 3-dimensional OV-like structures were derived
from the hiPSC lines (hiPSC-OVs) and differentiated into reti-
nal cell types in a manner analogous to human retinogenesis
in vivo [28, 31]. VSX2R200Q hiPSC-OVs demonstrated prolifera-
tion defects, enhanced RPE differentiation at the expense of
NR, and absence of bipolar cells, which closely approximates
the vertebrate disease phenotype [31]. Interestingly, RNA-seq
performed on early VSX2R200Q hiPSC-OVs revealed upregula-
tion of a striking number of genes belonging to the WNT
pathway, which led us to further examine the association
between VSX2 and WNT signaling during early retinal
differentiation.
In the present study, we show that major components of
the WNT pathway are gene targets for VSX2 binding during
retinal differentiation in hiPSCs, and that pharmocological
manipulation of the WNT pathway alters the expected pheno-
types of both wild-type control (VSX2WT) and VSX2R200Q
hiPSC-OVs. Our findings indicate an important role for VSX2
as a direct regulator of WNT signaling and suggest that VSX2
may maintain NR identity in early hiPSC-OVs in part by antag-
onizing expression of WNT pathway constituents.
MATERIALS AND METHODS
Cell Culture
hiPSCs derived from a microphthalmic patient[24] with homo-
zygous R200Q mutations in VSX2 and an unaffected sibling
were maintained on irradiated mouse embryonic fibroblasts
and differentiated toward retina as previously described [31].
Briefly, on day 0 (d0), embryoid bodies (EBs) are lifted with
2 mg/ml dispase in the absence of FGF2 to initiate retinal dif-
ferentiation. On d7, EBs are plated on laminin-coated wells,
and by d10, 90% of cells express markers of anterior neuroec-
toderm [26]. By d12, MITF expression is detected in a subset
of the cells, followed on d14 by expression of VSX2, which
marks the production of NRPCs [20]. By d18-20, NRPC and
RPE progenitors are established and OV structures consisting
predominantly of NRPCs are manually separated and cultured
en masse. These hiPSC-OVs subsequently generate all retinal
neuron types in a sequence and time frame approximating
normal human retinogenesis [29, 31].
Immunocytochemistry
EBs were plated on laminin-coated coverslips on d7 of retinal
differentiation and fixed with 4% paraformaldehyde after an
additional 7-11 days of differentiation. D35 and d50 hiPSC-
OVs were fixed for 1 hour at RT in 4% paraformaldehyde, cry-
opreserved in 15-30% sucrose, and cut into 11 mm cryosec-
tions. Samples were blocked in 10% normal donkey serum,
0.5% Triton X100, 1% fish gelatin, and 5% bovine serum albu-
min for 45 min at room temperature and incubated with pri-
mary antibody overnight at 48C in a humidified chamber
(primary antibody sources and dilutions are listed in Table
S1). AF546-, AF488-, and AF633-conjugated secondary anti-
bodies (Thermo Fisher) were diluted 1:500 in blocking buffer
and incubated at room temperature for 30 min. Samples
were mounted in Prolong Gold antifade1DAPI (Thermo
Fisher) and images were taken on a Nikon A1R-Si laser scan-
ning confocal microscope (Nikon). Cell counts were performed
with Nikon Elements module D and plotted with Graph Pad
Prism 6.
WNT Agonist and Antagonist Treatments
EBs were plated at d7 on laminin-coated plastic wells or
laminin-coated glass coverslips and treated with the WNT
antagonist IWP2 (5 mM) (Tocris) from d12 to d20 or with the
WNT agonist CHIR99021 (3 mM) (Tocris) from d14 to d20.
DMSO served as the vehicle control for all experiments.
Treated coverslips were fixed at d18 and immunostained as
described above. Treated wells were collected after 30 days of
differentiation and total RNA was extracted with RNAeasy
mini spin columns (Qiagen) and reverse transcribed with
iScript cDNA kit (BioRad) according to manufacturers’ instruc-
tions. Quantitative PCR was performed with SSO Advanced
SybrGreen master mix (BioRad) on a Step One Plus Real Time
PCR system (Thermo Fisher). Relative expression was normal-
ized to the geometric mean of two reference genes and the
average 2-DDCq6 SEM of three replicates was plotted using
Graph Pad Prism 6. Statistical significance (p< 0.05) was cal-
culated with an unpaired two-tailed Student’s t-test. Primer
sequences are listed in Table S2.
Chromatin Immunoprecipitation
Human iPSC-OVs were manually selected and differentiated to
d30, fixed in 1% formaldehyde for 10 min at room tempera-
ture, washed, and lysed in Pierce IP lysis buffer (Thermo
Fisher) supplemented with 40 ml/ml protease inhibitor cocktail
P8340 (Sigma Aldrich). Cleared lysate was sheared in a Q700
ultrasonic processor (Qsonica) equipped with a cup horn, and
shearing was monitored using 1% agarose gel electrophoresis.
10% volume was reserved for input and the remainder was
incubated with 2 mg sheep anti-VSX2 antibody (Exalpha) over-
night at 48C with rocking. Immunoprecipitates were collected
on protein-G conjugated Dynabeads (Thermo Fisher), washed
5x with sterile PBS, and eluted in 10 mM Tris/1 mM EDTA pH
81 1% SDS. Three volumes of 1% SDS, 0.1M NaHCO3, and
200 mM NaCl were added to input and IP samples and cross-
links were reversed by incubation at 658C for 4 hours. DNA
was extracted with phenol:chloroform:isoamyl alcohol, ethanol
precipitated, and quantified with the Qubit high sensitivity
double stranded DNA kit (Thermo Fisher). 8-10 ng of DNA
were prepared for deep sequencing with either the Illumina
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ChIP-Seq DNA or the TruSeq ChIP Sample Preparation Kit (Illu-
mina) and quantified with a Qubit fluorometer. All samples
were loaded at a final concentration of 8 pM and sequenced
on the Illumina HiSeq 2500.
ChIP-Seq Analysis
ChIP-seq reads were aligned to the hg19 Homo sapiens
assembly using Bowtie [32]. Duplicate reads were removed
within each replicate. Transcription factor binding sites were
first called after combining reads from both replicates using
the R software package SPP [33] with the following settings:
detection window halfsize5 300, False Discovery Rate
(FDR)5 0.05. After subtracting the normalized input read
counts [34], the number of ChIP binding reads were com-
puted for every binding site within each replicate, and only
sites having at least 10 ChIP binding reads within both repli-
cates were considered high confidence sites. Transcription fac-
tor binding motifs were analyzed in an unbiased fashion using
HOMER version 4.6 [35].
ChIP-PCR
Chromatin from both VSX2WT and VSX2R200Q hiPSC-OVs were
immunoprecipitated as described above and purified DNA was
diluted 1:10 for PCR. Genomic coordinates for selected WNT
pathway peaks were used to generate primers, and sites in
the MITF-H promoter known either to be bound or not to be
bound by VSX2 [20] were used as positive and negative con-
trols for these experiments, respectively. Primer sequences
are listed in Table S2 and PCR analysis was performed with 2X
PCR master mix (Promega) (35 cycles and Tm5 588C) followed
by visualization on a 2% agarose gel.
RESULTS
VSX2 Binds a Subset of WNT Pathway Genes
In a previous study, transcriptome comparison of VSX2WT and
VSX2R200Q hiPSC-OVs suggested a regulatory role for VSX2 in
WNT signaling, which in turn might contribute to the overpro-
duction of RPE at the expense of NR seen in mutant OVs [31].
To further investigate this possibility, we performed unbiased
searches for VSX2 DNA binding sites in two independent sam-
ples of d30 VSX2WT hiPSC-OVs using chromatin immunopreci-
pitation followed by massively parallel DNA sequencing (ChIP-
Seq). Western blot analysis of cell lysates and immunoprecipi-
tates demonstrated VSX2 antibody specificity (Fig. S1A),
although differences in binding affinities between lots of VSX2
polyclonal antibodies resulted in the second ChIP-seq display-
ing weaker signal strength. We then compared merged ChIP
and input samples for peak calling and further stipulated that
peaks be present in both replicates, which resulted in a list of
2038 high confidence VSX2 binding sites (Table S3). Examina-
tion of the DNA regions occupied by VSX2 in these analyses
revealed a consensus binding motif identical to that previ-
ously found for VSX2 in various mammalian systems (Fig. 1A)
[21, 24, 30]. Furthermore, 236 of these sites were located
within 2.5 kb of a transcription start site. The majority of
peaks were split between intronic and intergenic sequences
(Fig. 1B), characteristic of enhancer targets, and more than
half of the identified loci (1425 peaks) were associated with
protein-coding genes (Fig. 1C), indicative of VSX2’s role as a
transcriptional regulator. Notably, DAVID annotation clustering
[36, 37] not only identified numerous functions consistent
with the known roles of VSX2 in early OV development, but
also highlighted the WNT signaling pathway as a functional
target of VSX2 (Fig. 1D). Target sites were identified in multi-
ple WNT pathway genes, including WLS, AXIN2, and WNT1
(Table 1).
To verify the potential for the canonical WNT pathway to
serve as a direct target for VSX2 binding and regulation during
early hiPSC-OV differentiation, we performed confirmatory
ChIP-PCR analysis focusing on the three highest scoring WNT
pathway genes: WLS, WNT1, and AXIN2 (Fig. 1F; peak cover-
age for each is shown in Fig. 1E). Consensus binding sites
from the MITF-H promoter that were previously shown to be
either bound or unbound by VSX2 were also included as posi-
tive and negative controls, respectively (Fig. 1G) [20]. Two
additional WNT pathway genes, SMAD3 and LEF1, with strong
peaks in the first ChIP-seq analysis (peak coverage shown in
Fig. S1B) but not in the second (and thus not included in the
high confidence list) were also subjected to ChIP-PCR (Fig.
S1C). All five WNT targets were amplified from immunopreci-
pitates of d30 VSX2WT hiPSC-OVs, but not VSX2R200Q hiPSC-
OVs (Fig. 1F and Fig. S1C). Thus, our findings confirm that
these genes are direct targets for VSX2 binding during retinal
differentiation.
Misexpression of an Essential Canonical WNT Pathway
Component in Neural Retinal Progenitors in VSX2R200Q
hiPSC-OVs
To further investigate effects on the WNT pathway stemming
from the loss of VSX2 DNA binding ability, VSX2WT and
VSX2R200Q hiPSCs underwent retinal differentiation for 18
days, a time point at which the expression of MITF and VSX2
(indicative of RPE progenitors and NRPCs respectively)
becomes mutually exclusive [20]. D18 VSX2WT and VSX2R200Q
hiPSC-OVs were then immunostained for VSX2, MITF, and the
critical canonical WNT pathway protein WLS (also known as
GPR177), which is necessary for WNT secretion and activation
(Fig. 2A-F, Fig. S2) [38]. Expression of MITF was excluded from
VSX21 cells in VSX2WT hiPSC-OVs at d18, consistent with
VSX2’s known role as a repressor of MITF (Fig. 2A) [16, 18].
Similarly, WLS expression was observed in MITF1 (Fig 2B),
but not VSX21 (Fig 2C), cells at d18. In stark contrast, VSX21
cells in d18 VSX2R200Q hiPSC-OVs co-labeled with both MITF
and WLS (Fig. 2D-F).
We next examined hiPSC-OV cultures differentiated to
d35, a time point at which the RPE and NR domains are well-
established, and to d50, when RPE maturation and retinal
neurogenesis are fully underway [28, 29]. An abundant popu-
lation of VSX21 NRPCs was present in d35 VSX2WT hiPSC-
OVs, which did not co-label with MITF or WLS (Fig. 2G and H;
also see Fig. S2G and H). By d50, VSX2WT hiPSC-OVs consisted
primarily of VSX21 NRPCs with rare MITF1 RPE cells (Fig. 2I).
However, in d35 VSX2R200Q hiPSC-OVs, a subpopulation of
VSX21 cells continued to co-express MITF, although co-
labeling between VSX2 and WLS was no longer observed (Fig.
2J and K; also see Fig. S2J and K). By d50, VSX2R200Q hiPSC-
OVs contained MITF1 RPE with no detectable VSX21 cells
(Fig. 2L). Together, these data demonstrate that, in the
absence of functional VSX2 DNA binding activity, both MITF
and WLS exhibit abnormal and prolonged expression in VSX21
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cells. However, other factors must be involved in the regula-
tion of WLS expression in hiPSC-OVs, since it is eventually
turned off even in mutant NRPCs.
The Canonical WNT Pathway is Active in Early
VSX2R200Q hiPSC-OVs
We next asked whether there were differences in WNT signal-
ing activity between VSX2WT and VSX2R200Q hiPSC-OVs by
examining bCATENIN nuclear localization (NL), a hallmark of
canonical WNT pathway activation. For these experiments, we
focused on d14 cultures as they contain a transient mixed
population of MITF1/VSX2-, MITF1/VSX21, and MITF-/
VSX21 cells as uncommitted hiPSC-OV cells transition to
either NRPCs or early RPE precursors [20]. In VSX2WT hiPSC-
OVs, bCATENIN NL was detected in MITF1/VSX2- cells and
rare MITF1/VSX21 cells but not in MITF-/VSX21 cells (Fig.
3A-H; also see Fig. S3). In d14 VSX2R200Q hiPSC-OVs, only
MITF1/VSX2- and MITF1/VSX21 populations were present,
and many cells demonstrated bCATENIN NL (Fig. 3I-P; also see
Fig. S3). The percentage of VSX21/bCATENIN NL1 co-labeled
cells within the total VSX21 cell population was quantified,
revealing a mean of 0.376 0.90% double-positive cells in
VSX2WT cultures and 32.16 19.3% double-positive cells in
VSX2R200Q cultures (p5 .01) (Fig. 3Q). These results show that
Figure 1. VSX2 ChIP-seq and ChIP-PCR analyses demonstrating binding of VSX2 to WNT pathway genes in d30 VSX2WT but not
VSX2R200Q hiPSC-OVs. Confirmation of the VSX2 consensus binding motif in VSX2WT hiPSC-OV ChIP-seq target sequences (A). Distribution
of high confidence VSX2 DNA binding targets in VSX2WT hiPSC-OVs as categorized by genomic location (B) or RNA species (C). List of GO
terms with greater than 3-fold enrichment generated via DAVID functional analysis of high confidence ChIP-seq peaks (D). Peak localiza-
tion and genomic coverage maps (6200 bp toward the 50 or 30 end) for WLS, AXIN2, and WNT1 (red and blue lines represent forward
and reverse DNA strand reads, respectively). The top panel designates ChIP coverage and the lower panel shows the input control for
each gene (E). VSX2 ChIP-PCR from VSX2WT or VSX2R200Q d30 hiPSC-OVs confirming direct binding of VSX2WT, but not VSX2R200Q, to tar-
gets identified proximal to the WNT signaling pathway genes WLS, AXIN2, and WNT1 (F). Regions in the MITF-H promoter previously
shown by ChIP-PCR to be bound (1) or not bound (2) by VSX2[20] served as positive and negative controls, respectively (amplified
from the same chromatin preparation presented in panel F) (G). See also Fig. S1.
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inactivation of canonical WNT signaling coincides with the
onset of VSX2 expression in d14 VSX2WT hiPSC-OVs, whereas
WNT signaling remains active in cells expressing mutant
VSX2R200Q, which lacks DNA binding ability [21, 24, 30].
Pharmacological Manipulation of WNT Signaling
Interconverts Early VSX2WT and VSX2R200Q hiPSC-OV
Phenotypes
The observation that canonical WNT activity is inversely asso-
ciated with the presence of functional VSX2 suggested that
stimulation or inhibition of WNT signaling might alter the phe-
notypes of VSX2WT and VSX2R200Q hiPSC-OVs, respectively.
Since d12 through d20 represents the critical period for
hiPSC-OV formation, we applied pharmacological treatments
at various intervals within that time frame, followed by con-
tinued growth of cultures without exogenous WNT modula-
tion until d30. When VSX2WT hiPSC-OVs were treated with the
WNT agonist CHIR99021 beginning at d12, cultures were
pushed toward a nonretinal fate (data not shown). However,
when CHIR99021 treatment of VSX2WT hiPSC-OVs was initi-
ated on d14, aberrant MITF and VSX2 co-labeling was
detected on d18, analogous to what was observed in
VSX2R200Q hiPSC-OVs (Fig. 4A-C; compare Fig. 4C to Fig. 2D).
Control, vehicle-treated VSX2WT hiPSC-OVs showed the typical
segregation of VSX2 and MITF expression at d18 (Fig. 4D-F).
Upon removal of CHIR99021 at d20 and further culture to
d30, expression of WNT pathway (WLS and AXIN2) and RPE
(MITF and OTX2) genes were increased, whereas NR-related
genes (VSX2, SIX6, RX, FGF9) were down-regulated (Fig. 4G).
By contrast, CHIR99021 treatment of VSX2R200Q hiPSC-OVs
over the same time periods had no significant effect (data not
shown).
Next, VSX2R200Q hiPSC-OVs were treated with the WNT
inhibitor IWP2. Unlike WNT agonist treatment of VSX2WT
hiPSC-OVs, IWP2 treatment of VSX2R200Q hiPSC-OVs beginning
at d12 did not lead to the production of nonretinal lineages.
Thus, we applied IWP2 from d12 to d20 for all experiments.
When sampled at d18 (Fig. 4H-M), abundant VSX21 cells
were present in IWP2-treated hiPSC-OVs (Fig. 4H), similar to
vehicle-treated hiPSC-OVs (Fig. 4K). However, unlike vehicle-
treated cultures, MITF expression was no longer detected in
mutant VSX21 cells at d18 in the presence of IWP2 (compare
Fig. 4I to Fig. 4L). Likewise, when IWP2 treatment of
VSX2R200Q hiPSC-OVs was discontinued at d20, followed by an
additional 10 days of culture to promote further differentia-
tion, WNT and RPE gene expression decreased and NR-related
gene expression increased relative to d30 vehicle-treated
VSX2R200Q hiPSC-OVs (Fig. 4N). Thus, pharmacological blockade
of WNT signaling during early NR:RPE patterning partially res-
cues the VSX2R200Q hiPSC-OV phenotype at d30, while early
augmentation of WNT signaling in VSX2WT hiPSC-OVs mimics
the effects of the VSX2R200Q mutation.
DISCUSSION
The role of VSX2 as a transcriptional repressor is well-
documented, although the number of known gene targets for
VSX2 is small considering its pleiotropic effects throughout
retinogenesis [19, 30, 39–41]. One of the earliest and most
important functions of VSX2 is in the maintenance of a prolif-
erating pool of NRPCs in the developing OV, which it accom-
plishes at least in part by repressing MITF expression, as
demonstrated in both animal and hPSC model systems [16,
18, 20]. In this report we provide evidence that VSX2 can reg-
ulate expression of WNT pathway genes in early hiPSC-OVs,
and that repression of WNT signaling by VSX2 may contribute
to the maintenance of NR identity at the expense of RPE. Fur-
thermore, pharmacological manipulation of WNT signaling can
partially mimic or rescue the effects of a functional null VSX2
mutation in early hiPSC-OVs.
The Wnt pathway is necessary for axis formation and early
embryonic patterning, and also serves as an essential regula-
tor of neural and ocular development in part through the
canonical bCatenin/TCF/Lef transcriptional pathway [8, 9, 42,
43]. With specific regard to ocular development, Wnt signaling
is required for proper dorsal-ventral patterning, RPE produc-
tion, and optic cup morphogenesis in vivo [10, 11, 44–47].
Conditional knockout (CKO) of bCatenin at an early OV stage
in mouse resulted in transdifferentiation of RPE to VSX21
NRPCs, leading to partial duplication of the NR [10, 46]. Con-
versely, ectopic bCatenin activation at later OV stages caused
a thickened RPE layer with aberrant Mitf expression in the NR
[46]. Interestingly, Mitf, which acts as a regulator of RPE dif-
ferentiation and pigmentation, is a direct gene target for the
Wnt/bCatenin/Lef transcriptional complex, and Mitf null
mutations exhibit a similar RPE to NR phenotype as the
bCatenin CKO [4, 7].
The WNT pathway has also been exploited in order to
enrich for desired cell types in vitro [48, 49], including pro-
duction of NRPCs or RPE cells from hESCs and hiPSCs [50–53].
Our prior finding that the expression of multiple WNT-related
genes was dramatically increased in VSX2R200Q hiPSC-OVs led
us to further examine the relationship between VSX2 and the
WNT pathway using ChIP and massively parallel DNA sequenc-
ing. These analyses showed that VSX2 directly targets a host
Table 1. List of WNT-related genes identified by VSX2 ChIP-SEQ
ID Gene name
CXXC4 CXXC finger 4
DIXDC1 DIX domain containing 1
FBXW4 F-box and WD repeat domain containing 4
RSPO2 R-spondin 2 homolog (Xenopus laevis)
WWOX WW domain containing oxidoreductase
AXIN2 axin 2
CSNK1A1 casein kinase 1, alpha 1
CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa
DKK2 dickkopf homolog 2 (Xenopus laevis)
FRAT2 frequently rearranged in advanced T-cell lymphomas 2
FZD1 frizzled homolog 1 (Drosophila)
FZD5 frizzled homolog 5 (Drosophila)
FRZB frizzled-related protein
NXN nucleoredoxin
SFRP1 secreted frizzled-related protein 1
SFRP2 secreted frizzled-related protein 2
TLE1 similar to transducin-like enhancer of split 1
TCF7L2 transcription factor 7-like 2 (T-cell specific, HMG-box)
TLE4 transducin-like enhancer of split 4 (E(sp1)
homolog, Drosophila)
WLS WNT ligand secretion mediator
WNT1 wingless-type MMTV integration site family, member 1
WNT4 wingless-type MMTV integration site family, member 4
WNT7B wingless-type MMTV integration site family, member 7B
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of genes encoding critical WNT pathway constituents in early
hiPSC-OVs. Therefore, results from the present study, com-
bined with prior reports in hiPSCs [20] and animal models
[19, 21] showing direct regulation of MITF expression by
VSX2, suggest that VSX2 antagonizes RPE development on
multiple levels (Fig. 5). In addition to repressing MITF, VSX2 is
capable of downregulating expression of key WNT pathway
genes, including WLS, which is required for WNT trafficking
and secretion [38, 54], and AXIN2, which has a complex role
in both bCatenin destabilization and recruitment of key Wnt
receptor components to the cell membrane [55]. These exam-
ples, along with others (Tables 1 and S3), point to WNT path-
way components as important targets for VSX2-mediated
gene repression during early NR development in hiPSCs. How-
ever, the observation that WLS is eventually downregulated
even in VSX2R200Q mutant NRPCs indicates that gene regula-
tory mechanisms independent of VSX2 are also in place to
control expression of WNT pathway components in hiPSCs.
In summary, our findings indicate a heretofore unde-
scribed role for VSX2 as a regulator of WNT signaling during
Figure 2. Comparison of VSX2, MITF, and WLS localization in VSX2WT and VSX2R200Q hiPSC-OVs. D18 OVs from VSX2WT (A–C) or
VSX2R200Q (D–F) hiPSCs were immunostained for VSX2 (red) and MITF (green) (A, D), MITF (red) and WLS (green) (B, E), or VSX2 (red)
and WLS (green) (C, F). D35 and d50 VSX2WT hiPSC-OVs (G–I) were examined for VSX2 (red) and MITF (green) (G, I) or VSX2 (red) and
WLS (green) (H) expression and compared to d35 (J, K) and d50 (L) VSX2R200Q hiPSC-OVs. Identical images with DAPI-labeled nuclei are
shown in Fig. S2. Scale bars5 50 mm.
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Figure 3. bCATENIN localization in d14 VSX2WT and VSX2R200Q hiPSC-OVs. D14 VSX2WT (A–H) or VSX2R200Q (I–P) hiPSC-OVs were immu-
nolabeled with bCATENIN (green), VSX2 (red), and MITF (blue) primary antibodies. Examples of bCATENIN nuclear localization are desig-
nated by white arrows (E–H). Panels E–H and M–P are cropped magnifications of the outlined areas in panels A–D and I–L, respectively.
Also see Fig. S3 for identical images with bCATENIN and DAPI-labeled nuclei. (Q) Graph of percent of bCATENIN nuclear localization in
VSX21 nuclei for WT and R200Q d14 hiPSC-OVs. **p5 .01. Scale bars5 50 mm.
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retinal differentiation and suggest a mechanism whereby VSX2
maintains NR identity in part by regulation of WNT pathway
genes. This study also offers the first unbiased search for VSX2
binding sites in a mammalian developmental model system,
which may lead to the discovery of other genes and mecha-
nisms involved in the production and maintenance of early NR.
CONCLUSION
This study utilized an hiPSC model of a retinal developmental
disorder, combined with pharmacological manipulations, chro-
matin immunoprecipitation, and massively parallel DNA
sequencing to gain insight into a novel mechanism underlying
NR vs. RPE production during human retinogenesis. We show
that the NRPC transcriptional factor VSX2 is a direct regulator
of numerous WNT-related genes and that VSX2-mediated
antagonism of WNT signaling plays an important role in the
maintenance of NR identity at the expense RPE. Our findings
also underscore the utility of hiPSCs in investigating the ear-
liest stages of human ocular development, which are other-
wise inaccessible to study.
Figure 4. Interconversion of early VSX2WT and VSX2R200Q hiPSC-OV phenotypes by pharmacological manipulation of WNT signaling.
Immunocytochemistry analysis on d18 VSX2WT hiPSC-OVs treated with the WNT agonist CHIR99201 (A-C) or vehicle (D-F) showing VSX2
(red) and MITF (green) coexpression (A–C) or lack thereof (D–F). RT-qPCR analysis of d30 VSX2WT hiPSC-OVs treated from d14-d20 with
vehicle or CHIR99201 (G). Immunocytochemistry analysis on d18 VSX2R200Q hiPSC-OVs treated with the WNT inhibitor IWP2 (H-J) or
vehicle (K-M) showing lack of coexpression (H–J) or coexpression (K–M) of VSX2 (red) and MITF (green). (N) RT-qPCR analysis of d30
VSX2R200Q hiPSC-OVs treated from d12-d20 with vehicle or inhibitor. Nuclei are shown in blue. *p< .01; **p< .001;***p< .0001. Scale
bars5 50 mm.
Figure 5. Schematic model depicting the impact of VSX2-
mediated regulation of WNT signaling on early retinal patterning
in wild-type hiPSC-OVs, and the consequence of the (R200Q)VSX2
mutation. VSX2WT acts in multiple ways to maintain NR identity.
On a gene expression level, VSX2 antagonizes expression of WNT
pathway genes and MITF, resulting in the promotion of NR at the
expense of RPE in hiPSC-OVs (A). In the absence of functional
VSX2 (i.e., VSX2R200Q hiPSC-OVs), expression of WNT pathway
genes and MITF are unchecked, leading to RPE production over
NR (B).
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